[Treatment of catarrhal and catarrho-erosive colitis with Repredsol (a new combination drug for topical application)].
D000287:Administration, Topical; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D001888:Boric Acids / Q000627:therapeutic use; D003092:Colitis / Q000188:drug therapy*; D003093:Colitis, Ulcerative / Q000188:drug therapy*; D003109:Colonic Diseases, Functional / Q000188:drug therapy*; D004338:Drug Combinations; D004733:Enema; D006801:Humans; D011239:Prednisolone; D014801:Vitamin A / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D001888:Boric Acids; D004338:Drug Combinations; D014801:Vitamin A; C009164:Repredsol; D011239:Prednisolone
Lechenie na kataralnite i kataralno-erozinvnite khronichni koliti s repredzol.